• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

  • Home
  • About Us
    • Mission and History
    • Grace-Marie Turner bio
    • Who was Galen?
    • Donate to Galen
  • Activities
    • Core Activities
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Contact Us
  • Major Papers
  • Broadcast Interviews
  • Health Policy Consensus Group

Medicare Drugs on Chopping Block

POSTED BY Galen Institute on August 22, 2023.

The Biden administration is expected to announce, by Sept. 1, the first 10 prescription drugs it will target in its newly authorized drug price “negotiation” regime.

Under the Inflation Reduction Act (more properly dubbed the Innovation Reduction Act), the Centers for Medicare and Medicaid Services will announce the 10 drugs under Medicare Part D that the agency will subject to its Drug Price Negotiation Program.

Continue this article at the Daily Signal

Filed Under: Grace-Marie Turner, The Daily Signal

Primary Sidebar

SEARCH

NEW

An American Renaissance in the Care of Health

Our Annual Report

New Paths to Progress

The Laffer Curve

Subscribe to our Newsletter

* = required field
unsubscribe from list
(After subscribing, you will receive a confirmation email which is frequently found in the junk mail folder.)

Recent Newsletters

Categories

Social Media

Like Us On Facebook

Twitter:
@gracemarietweet
@galeninstitute

Copyright Galen Institute at Donors. © 2025; · Log in